- Home
- / Tetra Bio-Pharma
Tetra Bio-Pharma
Stock Price
$0
2023-11-17
Market Capitalization
$1.7 M
2023-11-17
Tetra Bio-Pharma Summary
Company Summary
- Overview
- Tetra Bio-Pharma is a company developing biopharmaceuticals and natural health products containing cannabis and other medicinal plant-based elements. Its products are designed for the therapeutic areas of pain, ophthalmology, and oncology.
- Type
- Public
- Status
- Active
- Founded
- 2015
- HQ
- Ottawa, CA | view all locations
- Cybersecurity rating
Table of Contents
Key People
Dale Weil, Director
Dania Scott, Sr. Vice President, Commercial Strategy
LocationsView all
2 locations detected
Ottawa, ON HQ
Canada
2316 St Joseph Blvd, Orléans
Longueuil, QC
Canada
365 Rue Saint-Jean #122
Tetra Bio-Pharma Financials
Summary Financials
- Gross profit (Q3, 2022)
- ($C2.0K)
- Net income (Q3, 2022)
- ($C3.5M)
- Cash (Q3, 2022)
- $C483.0K
- EBIT (Q3, 2022)
- ($C4.0M)
- Enterprise value
- $2.9M